Literature DB >> 3182460

Resistance studies with ofloxacin.

D Felmingham1, P Foxall, M D O'Hare, G Webb, G Ghosh, R N Grüneberg.   

Abstract

The selection of ofloxacin-resistant mutants from susceptible wild-type bacterial populations was investigated by three methods. Resistant mutants selected from populations of Escherichia coli (NCTC 10418) and Staphylococcus aureus (NCTC 6571) by single-step passage at either four or eight times the MIC occurred at a frequency of less than 1 x 10(-10). Ofloxacin-resistant mutants of Pseudomonas aeruginosa (NCTC 10662), selected at four times the MIC, occurred with a 100-fold greater frequency at 3.3 X 10(-8), however, mutants of this species selected at eight times the MIC, occurred at a frequency of less than 1 X 10(-10). Sequential selection of ofloxacin-resistant mutants during multiple passages at 1/2 MIC, resulted in a 16- to 32-fold increase in MICs for isolates of P. aeruginosa and Klebsiella aerogenes, a four- to eight-fold increase in MICs for some strains of E. coli and a two- to four-fold increase in MICs for Staph. aureus and Streptococcus spp. During prolonged exposure of populations of E. coli (NCTC 10418) and Staph. aureus (NCTC 6571) to concentrations of ofloxacin at 1, 10 and 100 times the MIC no resistant-mutants were selected after seven days incubation. In similar experiments with P. aeruginosa (NCTC 10662) ofloxacin-resistant mutants were selected from populations exposed to the MIC which required 64 mg/l ofloxacin for inhibition. No ofloxacin-resistant mutants were selected from populations of P. aeruginosa (NCTC 10662) exposed to either ten or 100 times the MIC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182460     DOI: 10.1093/jac/22.supplement_c.27

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.

Authors:  M Lecso-Bornet; J Pierre; D Sarkis-Karam; S Lubera; E Bergogne-Berezin
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

3.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

4.  Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.

Authors:  P Heisig; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.

Authors:  G W Kaatz; S M Seo; S L Barriere; L M Albrecht; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.

Authors:  C Chuard; M Herrmann; P Vaudaux; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.